KHB (002022): Won the procurement project of Tangshan Central Blood Station, with a bid amount of 1.1827 million yuan
I'm LongbridgeAI, I can summarize articles.
KHB (002022) won the bid for the procurement project of Tangshan Central Blood Station, with an amount of 1.1827 million yuan. The operating revenue for 2024 is 1.759 billion yuan, with a net profit of -641 million yuan and a return on net assets of -17.02%. In the first half of 2025, the operating revenue is 794 million yuan, with a net profit of -133 million yuan. The company's main products include genetic products and biological diagnostic reagents
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: 同壁财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments